Ryan Dunlap insider trades

Open-market stock purchases and sales by Ryan Dunlap, Director at CytoDyn Inc, from SEC Form 4 filings since Dec 31, 2012.

Recent trades

DateStockTradeValue
Mar 20, 2026CYDY CytoDyn IncBought (not open market)—

Companies traded

  • CYDY CytoDyn Inc: other filings, last Mar 20, 2026
  • GALE Galena Biopharma, Inc: 1 sale, last Jun 1, 2016

Get free alerts when Ryan Dunlap files a new trade →